Dexcom (DXCM) Receivables - Other (2018 - 2025)
Dexcom (DXCM) has disclosed Receivables - Other for 8 consecutive years, with $16.9 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other rose 11.18% to $16.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a 11.18% increase, with the full-year FY2025 number at $16.9 million, up 11.18% from a year prior.
- Receivables - Other was $16.9 million for Q4 2025 at Dexcom, up from $16.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $17.0 million in Q2 2025 to a low of $8.0 million in Q4 2023.
- A 5-year average of $11.7 million and a median of $10.2 million in 2022 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: dropped 16.22% in 2022, then soared 90.0% in 2024.
- Dexcom's Receivables - Other stood at $9.6 million in 2021, then dropped by 6.25% to $9.0 million in 2022, then dropped by 11.11% to $8.0 million in 2023, then skyrocketed by 90.0% to $15.2 million in 2024, then increased by 11.18% to $16.9 million in 2025.
- Per Business Quant, the three most recent readings for DXCM's Receivables - Other are $16.9 million (Q4 2025), $16.6 million (Q3 2025), and $17.0 million (Q2 2025).